BJL
NVAX icon

Brighton Jones LLC’s Novavax NVAX Stock Holding History

Brighton Jones LLC’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108K Buy
+11,427
New +$102K ﹤0.01% 1306
2022
Q1 		– Sell
-1,496
Closed -$214K – 537
2021
Q4 		$214K Buy
+1,496
New +$257K 0.01% 480

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Brighton Jones LLC's NVAX Position: Q2 2026 in Review

Brighton Jones LLC opened a new position in Novavax (NVAX) in Q2 2026: 11,427 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #1306 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in NVAX as recently as Q4 2021.

Brighton Jones LLC first reported a position in NVAX in Q4 2021 and has held it in 2 quarters since. The position peaked at $214K in Q4 2021. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Brighton Jones LLC held 11,427 shares of Novavax worth $108K as of Q2 2026.
  • Novavax was a new Brighton Jones LLC position in Q2 2026.
  • Novavax made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1306 holding.
  • Brighton Jones LLC first reported a position in Novavax in Q4 2021 and has held it in 2 quarters since.
  • Brighton Jones LLC's Novavax position peaked at $214K in Q4 2021.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.